5-HT1A modulator 2 hydrochloride

CAS No. 3880-76-0

5-HT1A modulator 2 hydrochloride( —— )

Catalog No. M28119 CAS No. 3880-76-0

5-HT1A modulator 2 hydrochloride is a modulator of 5-HT1A showing an affinity of 53 nM for 5-HT1A binding.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 39 In Stock
25MG 35 In Stock
50MG 47 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5-HT1A modulator 2 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    5-HT1A modulator 2 hydrochloride is a modulator of 5-HT1A showing an affinity of 53 nM for 5-HT1A binding.
  • Description
    5-HT1A modulator 2 hydrochloride is a modulator of 5-HT1A showing an affinity of 53 nM for 5-HT1A binding.
  • In Vitro
    5-HT1A modulator 2 hydrochloride (compound 3)binds to 5-HT1A with a Ki of 53 nM.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    B-Raf|C-Raf|PDGFRβ|FLT3|Kit|PDGFRα
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3880-76-0
  • Formula Weight
    213.71
  • Molecular Formula
    C11H16ClNO
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (467.95 mM)
  • SMILES
    Cl.COc1cccc2CCC(N)Cc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Eric A Murphy, et al. Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRbeta/B-RAF. Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4299-304.
molnova catalog
related products
  • Donitriptan

    Donitriptan is a 5-HT receptor agonist with pKis of 9.4 and 9.3 for 5-HT1B and 5-HT1D, respectively.

  • Nafronyl oxalate

    A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.

  • Lafutidine

    Lafutidine, a newly developed histamine H(2)-receptor antagonist, inhibits gastric acid secretion.